Clarfeld Financial Advisors’s Gilead Sciences GILD Stock Holding History

Clarfeld Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$19K	Buy	+295	New	+$20.6K	0.02%	163

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clarfeld Financial Advisors's GILD Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Gilead Sciences (GILD) in Q4 2018: 295 shares worth $19K. The stake represents 0.02% of the portfolio and ranks #163 among its holdings.

1,498 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Clarfeld Financial Advisors held 295 shares of Gilead Sciences worth $19K as of Q4 2018.
Gilead Sciences was a new Clarfeld Financial Advisors position in Q4 2018.
Gilead Sciences made up 0.02% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #163 holding.
1,498 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.